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A corrigendum on
Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for
complex traits: coronary heart disease as an example
by Goldstein, B. A., Knowles, J. W., Salfati, E., Ioannidis, J. P. A. and Assimes TL (2014). Front. Genet.
5:254. doi: 10.3389/fgene.2014.00254
The original Figure 2 did not display the full sample risk report as described in the paper. Here we
illustrate how one can convey personalized genetic risk to a patient and how the inclusion of the
Genetic Risk Score changes the clinical interpretation of the individual’s risk.
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YOUR RISK SCORE
Based on the traditional Framingham risk score, your risk of coronary heart disease over the next 10 years is approximately 5.5%.
We tested for a total of 90 possible risks variants or alleles. Out of these 90, you carry 49 variants that are associated with higher risk. Your genetic profile puts you in
the 89 percentile for risk. This means 89% of the general population have a genetic risk score more favorable than you and 11% have a genetic risk score less favorable
than you.
Based on the traditional Framingham risk score plus the genetic risk score, your risk of coronary heart disease over the next 10 years is approximately 7.6%.
Your 10 year risk of coronary heart disease risk is ≥7.5% when considering your genetic risk. This information may be discussed with your physician in terms of what
would be recommended as most appropriate management given your estimated risk.
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